Key facts
- This page summarizes Luca Santarelli's Form 3 filing for WINDWARD BIO GROUP AG (WWB).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Nov 2026, 18:16.
Luca Santarelli - 12 Nov 2026 Form 3 Insider Report for WINDWARD BIO GROUP AG (WWB)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- WWB
- Reported as of
- 12 Nov 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Scott Applebaum, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Luca Santarelli filed Form 3 for WINDWARD BIO GROUP AG (WWB) on 12 Nov 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002162137
Primary reporting owner
Santarelli Luca
- Relationship
- Chief Executive Officer, Director
- Address
- C/O WINDWARD BIO GROUP AG, AESCHENPLATZ 6, BASEL, SWITZERLAND
- Signature
- /s/ Scott Applebaum, Attorney-in-Fact
- Signature date
- 12 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
WWB
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,578,110
- Date
- 12 Nov 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
WWB
holding
Derivative
Employee Share Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 12 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 163,854
- Exercise price
- $0.0200
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
Footnote F2
The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.